Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,260
Total Claims
$843K
Drug Cost
888
Beneficiaries
$949
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+95%
Opioid rate vs peers
4.4% vs 2.2% avg
-33%
Cost per patient vs peers
$949 vs $1,411 avg
-2%
Brand preference vs peers
10.5% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
4.4%
Opioid Rate
448
Opioid Claims
$6,440
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,063 claims · $658K
Generic: 9,107 claims · $177K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 105 | $93K |
| Empagliflozin | 80 | $85K |
| Dulaglutide | 49 | $74K |
| Fluticasone/Umeclidin/Vilanter | 83 | $73K |
| Semaglutide | 29 | $41K |
| Fluticasone Propion/Salmeterol | 139 | $22K |
| Umeclidinium Brm/Vilanterol Tr | 37 | $20K |
| Insulin Glargine,hum.Rec.Anlog | 17 | $17K |
| Dapagliflozin Propanediol | 15 | $17K |
| Insulin Glargine,hum.Rec.Anlog | 19 | $14K |
| Rsvpref3 Antigen/As01e/Pf | 47 | $14K |
| Insulin Lispro | 11 | $14K |
| Insulin Glargine,hum.Rec.Anlog | 13 | $13K |
| Atorvastatin Calcium | 668 | $9,360 |
| Budesonide/Formoterol Fumarate | 14 | $8,246 |
Prescribing Profile
Patient Profile
76
Avg Age
55%
Female
1.51
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About